Legal Representation
Attorney
Brian O'Donnell
USPTO Deadlines
Next Deadline
31 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 30, 2025
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 30, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 30, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 12, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 12, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 12, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 12, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 12, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 12, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 15, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 15, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 7, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 7, 2024 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jun 7, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 7, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 7, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 7, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 28, 2024 | PBSR | Z | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | Loading... |
| May 18, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 17, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 17, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 17, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 17, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 23, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 2, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, compounds in a unitary solid dosage form made by a three-dimensional printing process for the rapid dispersion of a wide variety of therapeutic agents
Class 040
Pharmaceutical manufacturing to the order and/or specification of others
Class 042
Development of pharmaceutical and nutraceutical preparations for others; research and development in the pharmaceutical and nutraceutical fields for others
Additional Information
Design Mark
The mark consists of the stylized wording "APRECIA", with a broken arc originating from the bottom left leg of the initial letter "A" to the bottom right leg of the final letter "A" breaking between the letters "P", "R", "E", "C", "I", all displayed above "THE 3DP PHARMACEUTICAL COMPANY".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
APRECIA THE THREE DP PHARMACEUTICAL COMPANY
Classification
International Classes
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
3DP PHARMACEUTICAL COMPANY